The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
fei nuo bei te wei li zhi ji zai mei guo shang shi
Author(s): 
Pages: 368
Year: Issue:  6
Journal: World Clinical Drugs

Keyword:  诺贝商品名脂血症贝特血清甘油三酯肾脏疾病Abbott;
Abstract: Abbott和GroupeFournier公司的非诺贝特(fenofibrate)微粒制剂(商品名TriCor)目前在美国上市用于治疗单靠饮食疗法不能充分控制的、有胰腺炎危险的、血清甘油三酯水平>2000mg/dl的Ⅳ型和Ⅴ型高脂血症病人,本品不宜用于有肝脏、胆囊或严重肾脏疾病的病人。非诺贝特微粒制剂在美国上市@钟倩
Related Articles
No related articles found